Friends Research Institute, Inc.
63
9
14
41
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
4.8%
3 terminated/withdrawn out of 63 trials
93.2%
+6.7% vs industry average
19%
12 trials in Phase 3/4
54%
22 of 41 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (63)
Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail
Role: lead
Telemedicine XR-B for Individuals in Jail
Role: lead
Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform
Role: lead
Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care
Role: collaborator
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Role: collaborator
NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings
Role: collaborator
Optimal Intervention to Full Viral Suppression: Text Me, Alexis!
Role: lead
ASK-PrEP (Assistance Services Knowledge-PrEP)
Role: lead
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
Role: lead
Buprenorphine for Individuals in Jail
Role: lead
Long-acting Naltrexone for Pre-release Prisoners
Role: lead
Mobile Enhanced Prevention Support for People Leaving Jail
Role: collaborator
The Getting Off App for Methamphetamine-Using Gay and Bisexual Men
Role: lead
Mindfulness Based Stress Reduction App
Role: collaborator
Treating Polysubstance Use Using a Novel Digital Technology
Role: lead
NavSTAR Implementation Effectiveness Trial Across a Health System
Role: lead
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
Role: collaborator
Philly NavSTAR Implementation Trial
Role: lead
The Youth Opioid Recovery Support (YORS) Intervention
Role: collaborator
Low-dose Versus a High-dose Sublingual Buprenorphine Induction
Role: lead